Xikang Cloud Hospital Holdings (9686) H1 2024 earnings summary

Executive summary

• H1 revenue fell 18.1% YoY to RMB179.2m amid weak economic conditions and portfolio optimization; net loss narrowed 36.3% to RMB60.5m.

• Strategic focus shifted toward medical and nursing services delivered at home; home-care volume rose 217.3% as platform coverage expanded.

Financial highlights

• Revenue was RMB179.2m vs RMB218.9m; gross profit was RMB42.6m vs RMB67.3m, and gross margin fell 7.0 percentage points to 23.7%.

• Operating loss narrowed to RMB50.2m from RMB77.2m; adjusted net loss, excluding share-based compensation and redeemable-rights interest, was RMB51.3m vs RMB80.3m.

• Cost of sales and services decreased 9.9% to RMB136.7m; selling, R&D and administrative expenses declined 21.7%, 23.4% and 26.5%, respectively.

• Net finance costs fell to RMB5.5m from RMB16.8m, with no H1 2024 interest expense on redeemable rights; other income rose to RMB12.8m, mainly from grants and investment income.

Outlook and guidance

• Priorities include expanding city-specific cloud hospitals, broadening healthcare offerings and improving conversion of platform resources into services.

• Continued R&D investment in platform technology, big data, cloud computing and AI is intended to improve operations and support home medical and nursing services.

• Strategic ambition is to build a platform economy and a broad city-specific cloud hospital network, attracting healthcare and related ecosystem resources.